Butterfly Network, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph DeVivo
- Full Time Employees
- 220
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1600 District Avenue Burlington MA United States of America 01803
- IPO Date
- Jul 13, 2020
- CIK
- 0001804176
- Website
- butterflynetwork.com
- Similar Companies
- Business
- Butterfly Network, Inc. (NYSE: BFLY) develops, manufactures, and commercializes handheld ultrasound-on-chip technology and related software solutions for point-of-care medical imaging. The company offers whole-body ultrasound probes including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet; cloud-based software such as Compass for enterprise workflow integration, TeleGuidance, and AI-powered tools for image guidance and interpretation; educational platforms comprising in-app tutorials, ScanLab app, Butterfly Academy courses, and Butterfly Certified programs; and professional services for large-scale deployments. Butterfly Network, founded in 2011 and headquartered in Burlington, Massachusetts, operates primarily in the United States with international sales in regions including Europe, Asia, Africa, Australia, Indonesia, the Netherlands, and Belgium, targeting healthcare professionals, hospitals, clinics, veterinary practices, health systems, and medical education programs. In recent developments, the company launched the iQ3 ultrasound probe gaining traction in the U.S. and Europe with 55% product revenue growth; formed Octiv as a wholly-owned subsidiary to extend its Ultrasound-on-Chip technology into new sectors; expanded into new markets including Indonesia, the Netherlands, and Belgium driving 36% international revenue increase; initiated a Butterfly HomeCare pilot for AI-powered chronic care management with a Medicare Advantage provider; raised $75.6 million in post-IPO equity funding in January 2025 to enhance product lines and enter additional markets; and reported 5% revenue growth in Q3 2025 alongside advancements in AI tools for aortic valve imaging and gestational age assessment.
Butterfly Network CEO Joseph Devivo Sells 68,346 Shares
Butterfly Network's Co-Founder Wanted To Change The World, And He Is
Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director
Contrasting Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPF) and Butterfly Network (NYSE:BFLY)
BFLY Q2 Earnings Call Spotlights Embedded Growth and Raised Outlook
Butterfly Network, Inc. (BFLY) Q2 2026 Earnings Call Transcript
Butterfly Network Stock Jumps After Q2 Beat Fueled by Midjourney Partnership
Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Beats Revenue Estimates
Butterfly Network Reports Second Quarter 2026 Financial Results
Science Corp. Names Nevada Sanchez as Executive Vice President of Engineering
Butterfly Network Founder Rothberg Sells Another 660,000 Shares. Should Investors Worry?
Can AI Momentum and Embedded Growth Lift BFLY's Q2 Results?
Butterfly Network, Inc. (NYSE:BFLY) Receives Average Rating of “Hold” from Analysts
Butterfly Network's CEO Still Holds $51.3 Million in Stock After a 260% Run
What This Butterfly Network Filing Means Against $121 Million in Guidance and a Stock Up 260%
Butterfly Network to Report Second Quarter 2026 Financial Results on July 30, 2026
Jim Cramer Praises 'Miracle Worker' CEO, Says This Consumer Cyclical Stock Is ‘Too Hard To Own'
Butterfly Network Insider Sheds 399K Shares — This Stock May Be Ready to Take Flight
Butterfly Network Expands Handheld Ultrasound Reach in Brazil
BFLY's Embedded Partner Unveils Breakthrough in Brain Imaging Tech